Cargando…
INVICTUS: Vitamin K antagonists remain the standard of care for rheumatic heart disease-associated atrial fibrillation
Introduction: Rheumatic heart disease (RHD) remains a major healthcare problem. Atrial fibrillation (AF) is the commonest sustained arrhythmia in RHD, leading to major complications and morbidity in a young population. Currently, anticoagulation with vitamin K antagonists (VKA) is the mainstay of th...
Autor principal: | Kotit, Susy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Magdi Yacoub Heart Foundation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988293/ https://www.ncbi.nlm.nih.gov/pubmed/36890843 http://dx.doi.org/10.21542/gcsp.2023.6 |
Ejemplares similares
-
Lessons from a pre-specified meta-analysis of sodium-glucose cotransporter-2 (SGLT2) inhibitors in heart failure: Time for new clinical recommendations
por: Kotit, Susy
Publicado: (2023) -
EMMY: The continued expansion of clinical applications of SGLT2 inhibitors
por: Kotit, Susy
Publicado: (2023) -
Long-term outcomes from the UK Biobank on the impact of coffee on cardiovascular disease, arrhythmias, and mortality: Does the future hold coffee prescriptions?
por: Susy, Kotit
Publicado: (2023) -
Lessons from the first-in-human in vivo CRISPR/Cas9 editing of the TTR gene by NTLA-2001 trial in patients with transthyretin amyloidosis with cardiomyopathy
por: Kotit, Susy
Publicado: (2023) -
Diabetes and silent atrial fibrillation: A dangerous liaison?
por: Al Suwaidi, Jassim
Publicado: (2014)